Articles by David Blumberg - Pharmaceutical Executive


Articles by David Blumberg

David Blumberg

Newer Not Always Better
April 1, 2005

Developing first-in-class therapies is riskier and more labor intensive than filling pipelines with successor drugs. Can innovation remain the cornerstone of an industry reliant on "me toos"?

Networked Pharma
June 1, 2003

During the next ten years, big pharma companies will need to launch two products a year to generate 5 percent annual growth, five products a year to hit 10 percent growth, and nine products a year to meet a 15 percent annual growth target. Clearly, the stakes are high.


Click here